Patents-Review.com
🔗 Permalink
Assignee profile:

AMAZENTIS SA

City:

Ecublens

Country:

Switzerland

Published Applications:

15

Last publication date:

2020-07-16

Patent Grants:

15

Last grant date:

2021-11-23

Top Inventors for applications by AMAZENTIS SA

These are the the leading inventors for applications assigned to AMAZENTIS SA:

Recent patent applications by AMAZENTIS SA

AMAZENTIS SA based in Ecublens, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-07-16 ✅ Patent 11,180,468 granted on 2021-11-23
US20200223813A1
Chemistry; metallurgy

Prodrugs of urolithins and uses thereof

 #2 | 2020-05-07 ✅ Patent 10,988,453 granted on 2021-04-27
US20200140405A1
Chemistry; metallurgy

Compositions comprising an urolithin compound

 #3 | 2019-10-31 ✅ Patent 10,792,276 granted on 2020-10-06
US20190328703A1
Human necessities

Urolithins as immune response enhancers

 #4 | 2019-08-29 ✅ Patent 10,906,883 granted on 2021-02-02
US20190263772A1
Chemistry; metallurgy

Process-scale synthesis of urolithin A

 #5 | 2019-02-28 ✅ Patent 10,442,784 granted on 2019-10-15
US20190062297A1
Chemistry; metallurgy

Compositions comprising an urolithin compound

 #6 | 2019-01-10 ✅ Patent 11,166,972 granted on 2021-11-09
US20190008883A1
Human necessities

Compositions comprising nicotinamide riboside and a urolithin

 #7 | 2018-10-25 ✅ Patent 11,166,937 granted on 2021-11-09
US20180303794A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

 #8 | 2018-08-30 ✅ Patent 10,695,320 granted on 2020-06-30
US20180243261A1
Human necessities

Compositions comprising urolithin compounds

 #9 | 2017-05-25 ✅ Patent 10,857,126 granted on 2020-12-08
US20170143666A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

 #10 | 2016-11-10 ✅ Patent 9,573,922 granted on 2017-02-21
US20160326131A1
Chemistry; metallurgy

Process-scale synthesis of urolithins

 #11 | 2016-01-07 ✅ Patent 9,962,366 granted on 2018-05-08
US20160000753A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

 #12 | 2015-07-02 ✅ Patent 9,394,269 granted on 2016-07-19
US20150183758A1
Chemistry; metallurgy

Process-scale synthesis of urolithins

 #13 | 2014-01-16 ✅ Patent 11,020,373 granted on 2021-06-01
US20140018415A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

 #14 | 2012-06-28 ✅ Patent 9,872,850 granted on 2018-01-23
US20120164243A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

 #15 | 2011-03-17 ✅ Patent 8,933,217 granted on 2015-01-13
US20110065662A1
Human necessities

Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders

Also check out Amazentis SA's (Ecublens, Switzerland) applicant profile with 20 patent applications submitted.

AssigneeID:

145843 ⎘